| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 919,100 | 878,800 | 760,000 | 825,800 | | Cost of Revenue | 447,700 | 661,600 | 276,300 | 99,900 | | | Gross Profit | 471,400 | 217,200 | 483,700 | 725,900 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 41,200 | (233,300) | 37,100 | 315,400 | | Non Recurring | 1,800 | 36,200 | (54,900) | 10,700 | | Others | 161,300 | 142,500 | 126,000 | 115,200 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 267,100 | 271,800 | 375,500 | 284,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (130,500) | (77,000) | (15,800) | 24,600 | | Earnings Before Interest And Taxes | 138,200 | 193,700 | 358,200 | 307,300 | | Interest Expense | 31,800 | 28,600 | 32,800 | 32,500 | | Income Before Tax | 106,400 | 165,100 | 325,400 | 274,800 | | Income Tax Expense | 38,700 | 43,900 | 121,200 | 102,200 | | Minority Interest |
-
| (2,100) | (2,400) | (2,100) | | | | Net Income From Continuing Ops | 67,700 | 121,200 | 204,200 | 172,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 67,700 | 121,200 | 204,200 | 172,600 | | Preferred Stock And Other Adjustments | (500) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $67,200 | $121,200 | $204,200 | $172,600 |
|
0.45% Nasdaq 
0.20%
Income Statement
